JP2007502283A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007502283A5 JP2007502283A5 JP2006523322A JP2006523322A JP2007502283A5 JP 2007502283 A5 JP2007502283 A5 JP 2007502283A5 JP 2006523322 A JP2006523322 A JP 2006523322A JP 2006523322 A JP2006523322 A JP 2006523322A JP 2007502283 A5 JP2007502283 A5 JP 2007502283A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- alkyl
- cycloalkyl
- aryl
- hydrogen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 0 *c(ccc(**CN(*)*)c1)c1N(*)C(N(*)*)=O Chemical compound *c(ccc(**CN(*)*)c1)c1N(*)C(N(*)*)=O 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US49485503P | 2003-08-13 | 2003-08-13 | |
| PCT/US2004/025970 WO2005019240A2 (en) | 2003-08-13 | 2004-08-11 | Melanin concentrating hormone receptor antagonists |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007502283A JP2007502283A (ja) | 2007-02-08 |
| JP2007502283A5 true JP2007502283A5 (enExample) | 2007-06-28 |
Family
ID=34215905
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006523322A Withdrawn JP2007502283A (ja) | 2003-08-13 | 2004-08-11 | メラニン凝集ホルモン受容体アンタゴニスト |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20050256161A1 (enExample) |
| EP (1) | EP1654225A4 (enExample) |
| JP (1) | JP2007502283A (enExample) |
| AU (1) | AU2004266228A1 (enExample) |
| CA (1) | CA2534428A1 (enExample) |
| MX (1) | MXPA06001638A (enExample) |
| WO (1) | WO2005019240A2 (enExample) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1657242A4 (en) | 2003-08-15 | 2008-10-29 | Banyu Pharma Co Ltd | imidazopyridine |
| US7550499B2 (en) * | 2004-05-12 | 2009-06-23 | Bristol-Myers Squibb Company | Urea antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions |
| WO2006078621A2 (en) * | 2005-01-19 | 2006-07-27 | Bristol-Myers Squibb Company | 2-phenoxy-n- (1, 3 , 4-thiadizol-2-yl) pyridin-3-amine derivatives and related compounds as p2y1 receptor inhibitors for the treatment of thromboembolic disorders |
| AU2006232871B9 (en) * | 2005-04-01 | 2011-11-24 | Eli Lilly And Company | Histamine H3 receptor agents, preparation and therapeutic uses |
| WO2007002634A1 (en) * | 2005-06-27 | 2007-01-04 | Bristol-Myers Squibb Company | Carbocycle and heterocycle antagonists of p2y1 receptor useful in the treatment of thrombotic conditions |
| ATE502924T1 (de) * | 2005-06-27 | 2011-04-15 | Bristol Myers Squibb Co | Lineare harnstoffmimetika-antagonisten des p2y1- rezeptors zur behandlung von thromboseleiden |
| TW200726764A (en) * | 2005-06-27 | 2007-07-16 | Bristol Myers Squibb Co | N-linked heterocyclic antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions |
| DE602006017694D1 (de) * | 2005-06-27 | 2010-12-02 | Bristol Myers Squibb Co | C-verknüpfte zyklische antagonisten des p2y1-rezeptors mit eignung bei der behandlung thrombotischer leiden |
| ATE429428T1 (de) | 2005-09-30 | 2009-05-15 | Hoffmann La Roche | Indanderivate als antagonisten des mch-rezeptors |
| EP2061767B1 (de) | 2006-08-08 | 2014-12-17 | Sanofi | Arylaminoaryl-alkyl-substituierte Imidazolidin-2,4-dione, Verfahren zu ihrer Herstellung, diese Verbindungen enthaltende Arzneimittel und ihre Verwendung |
| US7960569B2 (en) * | 2006-10-17 | 2011-06-14 | Bristol-Myers Squibb Company | Indole antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions |
| UY31968A (es) | 2008-07-09 | 2010-01-29 | Sanofi Aventis | Nuevos derivados heterocíclicos, sus procesos para su preparación, y sus usos terapéuticos |
| WO2010068601A1 (en) | 2008-12-08 | 2010-06-17 | Sanofi-Aventis | A crystalline heteroaromatic fluoroglycoside hydrate, processes for making, methods of use and pharmaceutical compositions thereof |
| WO2010098866A1 (en) | 2009-02-27 | 2010-09-02 | Supergen, Inc. | Cyclopentathiophene/cyclohexathiophene dna methyltransferase inhibitors |
| KR20120060207A (ko) | 2009-08-26 | 2012-06-11 | 사노피 | 신규한 결정성 헤테로방향족 플루오로글리코시드 수화물, 이들 화합물을 포함하는 약제 및 이들의 용도 |
| AU2011329233A1 (en) | 2010-11-15 | 2013-05-23 | Abbvie Deutschland Gmbh & Co Kg | NAMPT and ROCK inhibitors |
| US8895547B2 (en) | 2011-03-08 | 2014-11-25 | Sanofi | Substituted phenyl-oxathiazine derivatives, method for producing them, drugs containing said compounds and the use thereof |
| EP2683699B1 (de) | 2011-03-08 | 2015-06-24 | Sanofi | Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
| WO2012120058A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Mit benzyl- oder heteromethylengruppen substituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
| EP2766349B1 (de) | 2011-03-08 | 2016-06-01 | Sanofi | Mit carbozyklen oder heterozyklen substituierte oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung |
| US8828994B2 (en) | 2011-03-08 | 2014-09-09 | Sanofi | Di- and tri-substituted oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof |
| WO2012120051A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Mit adamantan- oder noradamantan substituierte benzyl-oxathiazinderivate, diese verbindungen enthaltende arzneimittel und deren verwendung |
| EP2683702B1 (de) | 2011-03-08 | 2014-12-24 | Sanofi | Neue substituierte phenyl-oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung |
| WO2012120056A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Tetrasubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
| EP2683704B1 (de) | 2011-03-08 | 2014-12-17 | Sanofi | Verzweigte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
| HU230880B1 (hu) | 2015-04-15 | 2018-11-29 | Richter Gedeon Nyrt | Indol származékok |
| ES2735924T3 (es) * | 2015-04-17 | 2019-12-20 | Dow Agrosciences Llc | Moléculas que tienen utilidad plaguicida e intermediarios, composiciones y procesos, relacionados con ellas |
| CN107949279A (zh) | 2015-07-06 | 2018-04-20 | 得克萨斯系统大学评议会 | 可用作用于治疗人类癌症的抗癌剂的苯甲酰胺或苯扎明化合物 |
| BR122020018163B8 (pt) * | 2016-10-12 | 2022-09-06 | Dow Agrosciences Llc | Moléculas tendo utilidade pesticida, e intermediários, composições, processos relacionados às mesmas e sementes resistentes a pragas |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2730174C2 (de) * | 1977-07-04 | 1981-12-10 | Ludwig Merckle Kg Chem. Pharm. Fabrik, 7902 Blaubeuren | Aminobenzoesäurederivate und Arzneimittel enthaltend solche Aminobenzoesäurederivate |
| AU2859984A (en) * | 1983-05-23 | 1984-11-29 | Usv Pharmaceutical Corp. | Compounds for treating hypertension |
| GB0001447D0 (en) * | 2000-01-21 | 2000-03-08 | Novartis Ag | Organic compounds |
| JP4025200B2 (ja) * | 2000-12-22 | 2007-12-19 | シェーリング コーポレイション | ピペリジンｍｃｈアンタゴニストおよび肥満の処置におけるそれらの使用 |
| DE10123958A1 (de) * | 2001-05-17 | 2002-11-28 | Aventis Pharma Gmbh | Verfahren zur Identifizierung von Liganden für G protein coupled receptors |
| PE20021091A1 (es) * | 2001-05-25 | 2003-02-04 | Aventis Pharma Gmbh | Derivados de fenilurea sustituidos con carbonamida y procedimiento para su preparacion |
| US6552188B2 (en) * | 2001-06-29 | 2003-04-22 | Kowa Co., Ltd. | Unsymmetrical cyclic diamine compound |
| DE10139416A1 (de) * | 2001-08-17 | 2003-03-06 | Aventis Pharma Gmbh | Aminoalkyl substituierte aromatische Bicyclen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
| AU2002352878B2 (en) * | 2001-11-27 | 2007-11-22 | Merck Sharp & Dohme Corp. | 2-Aminoquinoline compounds |
| US6818772B2 (en) * | 2002-02-22 | 2004-11-16 | Abbott Laboratories | Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor |
| WO2003087044A2 (en) * | 2002-04-09 | 2003-10-23 | 7Tm Pharma A/S | Novel carboxamide compounds for use in mch receptor related disorders |
| WO2003087046A1 (en) * | 2002-04-09 | 2003-10-23 | 7Tm Pharma A/S | Novel aminotetraline compounds for use in mch receptor related disorders |
| US7078430B2 (en) * | 2002-07-08 | 2006-07-18 | Ranbaxy Laboratories Limited | HMG CoA-reductase inhibitors |
| FR2842524B1 (fr) * | 2002-07-16 | 2005-04-22 | Aventis Pharma Sa | Compositions pharmaceutiques contenant un derive de 3-guanidinocarbonyl-1-heteroaryl-pyrrole, leur procede de preparation a titre de medicaments |
| US7091235B2 (en) * | 2002-10-15 | 2006-08-15 | Signal Pharmaceuticals, Llc | Benzopyranone compounds, compositions thereof, and methods for treating or preventing cancer |
-
2004
- 2004-08-11 EP EP04780754A patent/EP1654225A4/en not_active Withdrawn
- 2004-08-11 JP JP2006523322A patent/JP2007502283A/ja not_active Withdrawn
- 2004-08-11 WO PCT/US2004/025970 patent/WO2005019240A2/en not_active Ceased
- 2004-08-11 MX MXPA06001638A patent/MXPA06001638A/es active IP Right Grant
- 2004-08-11 AU AU2004266228A patent/AU2004266228A1/en not_active Abandoned
- 2004-08-11 US US10/916,219 patent/US20050256161A1/en not_active Abandoned
- 2004-08-11 CA CA002534428A patent/CA2534428A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007502283A5 (enExample) | ||
| JP6193922B2 (ja) | ハロアルキルヘテロアリールベンズアミド化合物 | |
| ES2873949T3 (es) | Moduladores del receptor de glucocorticoides de azadecalina condensada con heteroaril-cetona | |
| TW444013B (en) | Quinoline and quinazoline compounds useful in treating benign prostatic hyperplasia | |
| RU2010129724A (ru) | 4-(4-циано-2-тиоарил)-дигидропиримидиноны и их применение | |
| JP4294960B2 (ja) | 抗癌剤としてのサイクリン依存性キナーゼ阻害剤 | |
| RU2007111711A (ru) | Производные трициклического лактама в качестве ингибиторов 11-бэта-гидроксистероидной дегидрогеназы | |
| DE69208263T2 (de) | Substituierte aminopyrimidine als angiotensin ii antagonisten | |
| RU2009113585A (ru) | Производные дибензофурана в качестве ингибиторов pde-4 и pde-10 | |
| JP2007502287A5 (enExample) | ||
| JP2016053078A (ja) | がん及び非新生物性状態の治療方法 | |
| JP2013542996A5 (enExample) | ||
| JP2010502689A5 (enExample) | ||
| JO3429B1 (ar) | مشتقات برميدينات مثبطة فيروس الايدز | |
| JP2005523254A5 (enExample) | ||
| JP2011507878A5 (enExample) | ||
| RU2010147404A (ru) | Замещенные дигидропиразолоны в качестве ингибиторов hif-пролил-4-гидроксилазы | |
| JP2007530601A5 (enExample) | ||
| JP2006502119A5 (enExample) | ||
| JP2972377B2 (ja) | カテコール誘導体、その薬学的に許容しうる塩およびエステルならびにそれらを含有する医薬組成物 | |
| CN1997366A (zh) | 作为抗病毒剂的咪唑和噻唑衍生物 | |
| JP2011507879A5 (enExample) | ||
| AU2015346413A1 (en) | Compositions and methods of treatment with prodrugs of tizoxanide, an analogue or salt thereof | |
| JP2020500866A5 (enExample) | ||
| JP2014514290A5 (enExample) |